These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 22377926)

  • 1. Late effects after hematopoietic stem cell transplantation--critical issues.
    Tichelli A; Rovó A; Socié G
    Curr Probl Dermatol; 2012; 43():132-49. PubMed ID: 22377926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late complications after hematopoietic stem cell transplantation.
    Tichelli A; Rovó A; Passweg J; Schwarze CP; Van Lint MT; Arat M; Socié G;
    Expert Rev Hematol; 2009 Oct; 2(5):583-601. PubMed ID: 21083023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survivorship after allogeneic transplantation-management recommendations for the primary care provider.
    Tichelli A; Rovó A
    Curr Hematol Malig Rep; 2015 Mar; 10(1):35-44. PubMed ID: 25667128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life, social challenges, and psychosocial support for long-term survivors after allogeneic hematopoietic stem-cell transplantation.
    Norkin M; Hsu JW; Wingard JR
    Semin Hematol; 2012 Jan; 49(1):104-9. PubMed ID: 22221790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The late effects in patients treated with allogeneic hematopoietic stem cell transplantation].
    Roziaková L; Bojtárová E; Mistrík M; Mladosievicová B
    Klin Onkol; 2011; 24(6):453-9. PubMed ID: 22257235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health status, late effects and long-term survivorship of allogeneic bone marrow transplantation: a retrospective study.
    Gifford G; Sim J; Horne A; Ma D
    Intern Med J; 2014 Feb; 44(2):139-47. PubMed ID: 24320824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular complications in long-term survivors after allogeneic hematopoietic stem cell transplantation.
    Rovó A; Tichelli A;
    Semin Hematol; 2012 Jan; 49(1):25-34. PubMed ID: 22221782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for late infections after allogeneic hematopoietic stem cell transplantation from a matched related donor.
    Robin M; Porcher R; De Castro Araujo R; de Latour RP; Devergie A; Rocha V; Larghero J; Adès L; Ribaud P; Mary JY; Socié G
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1304-12. PubMed ID: 17950917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term health-related quality of life, growth, and spiritual well-being after hematopoietic stem-cell transplantation.
    Andrykowski MA; Bishop MM; Hahn EA; Cella DF; Beaumont JL; Brady MJ; Horowitz MM; Sobocinski KA; Rizzo JD; Wingard JR
    J Clin Oncol; 2005 Jan; 23(3):599-608. PubMed ID: 15659507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of cumulative anthracycline dose, preparative regimen and chronic graft-versus-host disease on pulmonary and cardiac function in children 5 years after allogeneic hematopoietic stem cell transplantation: a prospective evaluation on behalf of the EBMT Pediatric Diseases and Late Effects Working Parties.
    Uderzo C; Pillon M; Corti P; Tridello G; Tana F; Zintl F; Nysom K; Galambrun C; Fagioli F; Varotto S; Messina C; Verdeguer A; Urban C; Faraci M; Dini G; Fedeli S; Tichelli A; Rovelli A; Socié G
    Bone Marrow Transplant; 2007 Jun; 39(11):667-75. PubMed ID: 17401396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The A-B-C of haematopoietic stem cell transplantation.
    Rafeah NT; Fadilah SA
    Med J Malaysia; 2009 Mar; 64(1):94-100; quiz 101. PubMed ID: 19852335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The burden of cure: long-term side effects following hematopoietic stem cell transplantation (HSCT) in children.
    Baker KS; Bresters D; Sande JE
    Pediatr Clin North Am; 2010 Feb; 57(1):323-42. PubMed ID: 20307723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation.
    Tichelli A; Passweg J; Wójcik D; Rovó A; Harousseau JL; Masszi T; Zander A; Békássy A; Crawley C; Arat M; Sica S; Lutz P; Socié G;
    Haematologica; 2008 Aug; 93(8):1203-10. PubMed ID: 18556401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High rate of long-term survival for high-risk lymphoma patients treated with hematopoietic stem cell transplantation as consolidation or salvage therapy.
    Espigado I; Ríos E; Marín-Niebla A; Carmona M; Parody R; Pérez-Hurtado JM; Márquez FJ; Urbano-Ispizua A
    Transplant Proc; 2008 Nov; 40(9):3104-5. PubMed ID: 19010208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High burden of late effects after haematopoietic stem cell transplantation in childhood: a single-centre study.
    Bresters D; van Gils IC; Kollen WJ; Ball LM; Oostdijk W; van der Bom JG; Egeler RM
    Bone Marrow Transplant; 2010 Jan; 45(1):79-85. PubMed ID: 19421172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic hematopoietic stem cell transplantation (HSCT) after reduced intensity conditioning.
    Servais S; Baron F; Beguin Y
    Transfus Apher Sci; 2011 Apr; 44(2):205-10. PubMed ID: 21345734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survivorship issues in hematopoietic stem cell transplantation.
    Buchsel PC
    Semin Oncol Nurs; 2009 May; 25(2):159-69. PubMed ID: 19411019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up and management guidelines in pediatric patients after allogenic hematopoietic stem cell transplantation.
    Frangoul H; Najjar J; Simmons J; Domm J
    Semin Hematol; 2012 Jan; 49(1):94-103. PubMed ID: 22221789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting factors for admission to an intensive care unit and clinical outcome in pediatric patients receiving hematopoietic stem cell transplantation.
    Diaz MA; Vicent MG; Prudencio M; Rodriguez F; Marin C; Serrano A; Sevilla J; Casado J; Madero L
    Haematologica; 2002 Mar; 87(3):292-8. PubMed ID: 11869942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.